Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
What it means
- What to watch: There is a hard number in this story (16%) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $AXSM -9.23% in the latest session.
- Timing: Weekend news: the change beside it is Friday's, and Monday's open is the first session that gets a say. Market holidays are not detected.
Where the stock stands
$AXSM last traded at $131.10, -9.23% on the session. That puts it 50% shy of its 52-week high of $260.19 and 6.6% clear of its low of $123.00 — within a tenth of its 52-week low. Over the year it has ranged 112% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $AXSM page.
How much coverage it is getting
Wook has logged 2 stories on $AXSM in the last 30 days, 1 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 1 read bullish, 1 neutral and 0 bearish. This one reads neutral, so it sits in step with most of the run. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
Coming up
$AXSM earnings today, Monthly options expiration in 18 days and FOMC decision in 37 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
The $AXSM page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $AXSM sits from its high, or how this week's coverage stacks up.
How this analysis was made
Yahoo Finance published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $AXSM. It carried 16%, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Yahoo Finance published this on August 23, 2026. $AXSM has moved -36.18% ($205.40 to $131.09). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.